Figure 2.
Cumulative incidence of grade 3-4 acute GvHD in patients receiving myeloablative (MAC) and non-myeloablative (NMA)/reduced-intensity (RIC) conditioning regimens
Cumulative incidence of grade 3-4 acute GvHD in patients receiving myeloablative (MAC) and non-myeloablative (NMA)/reduced-intensity (RIC) conditioning regimens